a suggestive trendp = 0.06
The Q3 group also exhibited increased mortality at 1 month (aHR 1.94 [95% CI 1.07–3.5], p = 0.03), with a suggestive trend at 1 year but not reaching significance (aHR 1.50 [95% CI 0.98–2.30], p = 0.06).
The Q3 group also exhibited increased mortality at 1 month (aHR 1.94 [95% CI 1.07–3.5], p = 0.03), with a suggestive trend at 1 year but not reaching significance (aHR 1.50 [95% CI 0.98–2.30], p = 0.06).
Sensitivity analysis also produced consistent results with the main analyses across quartiles regarding a trend towards increased creatinine levels (P trend = 0.03), bilirubin (P trend < 0.01), and NtproBNP (P trend < 0.01), along with a decreasing trend for haemoglobin (P trend < 0.01) and tricuspid annular plane systolic excursion (TAPSE) (P trend = 0.03).
Based on our adapted classification, 38 patients (9.4%) were categorized as SCAI shock stage B, 146 (36.0%) as SCAI stage C, 213 (52.5%) as SCAI stage D, and 9 (2.2%) as SCAI stage E, with a significant trend towards an increase in the proportion of stage D across the quartiles (P trend < 0.01).